Initial Testing (Stage 1) of the Multi-targeted Kinase Inhibitor Sorafenib by the Pediatric Preclinical Testing Program

BACKGROUND: Sorafenib is an inhibitor of multiple kinases (e.g., VEGF receptors, PDGFR, FLT3, RET, BRAF, KIT) and is approved by FDA for treatment of two adult cancers. The activity of sorafenib was evaluated against the PPTP's in vitro and in vivo panels. PROCEDURES: Sorafenib was evaluated ag...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Keir, Stephen T., Maris, John M., Lock, Richard, Kolb, E. Anders, Gorlick, Richard, Carol, Hernan, Morton, Christopher L., Reynolds, C. Patrick, Kang, Min H., Watkins, Amy, Houghton, Peter J., Smith, Malcolm A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3823056/
https://ncbi.nlm.nih.gov/pubmed/20672370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22712
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados